selected publications
- Importance of a multi-tiered treatment approach for intellectually and developmentally disabled patients with hidradenitis suppurativa. Archives of dermatological research. 2023 Academic Article GET IT
- Serum inflammatory markers and leukocyte profiles accurately describe hidradenitis suppurativa disease severity. International journal of dermatology. 2022 Academic Article GET IT
- Antiandrogen therapy in hidradenitis suppurativa: finasteride for females. Clinical and experimental dermatology. 2021 Academic Article GET IT
- Persistent Panniculitis in Dermatomyositis. Cutis. 2021 Letter GET IT
-
Patient satisfaction with hidradenitis suppurativa televisits correlates with less severe disease.
Journal of the American Academy of Dermatology.
2021
Academic Article
GET IT
Times cited: 1 -
Impact of Treatment With TNF-α Inhibitors for Hidradenitis Suppurativa During the COVID-19 Pandemic.
Journal of cutaneous medicine and surgery.
2021
Letter
GET IT
Times cited: 3 -
Treatment of melasma: a review of less commonly used antioxidants.
International journal of dermatology.
2020
Review
GET IT
Times cited: 2 -
Efficacy of high-dose intralesional triamcinolone for hidradenitis suppurativa.
International journal of dermatology.
2020
Academic Article
GET IT
Times cited: 4 -
The Therapeutic Use of Antioxidants for Melasma.
Journal of drugs in dermatology : JDD.
2020
Review
GET IT
Times cited: 7 -
Comment on: "Efficacies and merits of the cotton swab technique for diagnosing tinea capitis in the pediatric population".
Journal of the American Academy of Dermatology.
2020
Letter
GET IT
Times cited: 1 -
An exploratory study of IV metoclopramide+diphenhydramine for acute post-traumatic headache.
The American journal of emergency medicine.
2017
Academic Article
GET IT
Times cited: 25